JDVFX | VIVIX | JDVFX / VIVIX | |
Total Expense Ratio | 0.85 | 0.04 | 2,125% |
Annual Report Gross Expense Ratio | 0.96 | 0.04 | 2,400% |
Fund Existence | 16 years | 27 years | - |
Gain YTD | -9.524 | -7.289 | 131% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.2B | 195B | 8% |
Annual Yield % from dividends | 0.86 | 2.27 | 38% |
Returns for 1 year | -15.99 | -1.55 | 1,032% |
Returns for 3 years | -11.29 | 6.83 | -165% |
Returns for 5 years | 48.48 | 82.54 | 59% |
Returns for 10 years | 13.50 | 87.57 | 15% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BRLN | 50.64 | -0.68 | -1.33% |
iShares Floating Rate Loan Active ETF | |||
XSVM | 46.10 | -1.57 | -3.29% |
Invesco S&P SmallCap Value with Momt ETF | |||
EWZ | 24.50 | -1.83 | -6.95% |
iShares MSCI Brazil ETF | |||
EDEN | 94.58 | -7.29 | -7.16% |
iShares MSCI Denmark ETF | |||
HELX | 24.93 | -2.10 | -7.78% |
Franklin Genomic Advancements ETF |